A large-scale cancer-specific protein–DNA interaction network
Open Access
- 16 July 2024
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (10) , e202402641
Abstract
Cancer development and progression are generally associated with gene dysregulation, often resulting from changes in the transcription factor (TF) sequence or expression. Identifying key TFs involved in cancer gene regulation provides a framework for potential new therapeutics. This study presents a large-scale cancer gene TF-DNA interaction network, as well as an extensive promoter clone resource for future studies. Highly connected TFs bind to promoters of genes associated with either good or poor cancer prognosis, suggesting that strategies aimed at shifting gene expression balance between these two prognostic groups may be inherently complex. However, we identified potential for oncogene-targeted therapeutics, with half of the tested oncogenes being potentially repressed by influencing specific activators or bifunctional TFs. Finally, we investigate the role of intrinsically disordered regions within the key cancer-related TF ESR1 in DNA binding and transcriptional activity, and found that these regions can have complex trade-offs in TF function. Altogether, our study broadens our knowledge of the TFs involved in cancer gene regulation and provides a valuable resource for future studies and therapeutics.Keywords
All Related Versions
Funding Information
- National Institute of General Medical Sciences (R35 GM128625)
- HHS | NIH | National Cancer Institute (U01 CA232161)
- HHS | NIH | National Institute of General Medical Sciences (R35 GM147254)
This publication has 70 references indexed in Scilit:
- Enhanced Yeast One-Hybrid Assays to Study Protein–DNA Interactions2022
- Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid ProductionEndocrine Pathology, 2022
- Transcription factor AP‐2beta in development, differentiation and tumorigenesisInternational Journal of Cancer, 2021
- Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axisClinical and Translational Oncology, 2019
- Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cellsCurrent Medical Science, 2017
- Molecular mechanism of estrogen–estrogen receptor signalingReproductive Medicine and Biology, 2016
- Modeling Survival Data: Extending the Cox Model2000
- Dysregulated expression of growth factors and their receptors in the development of prostate cancerThe Prostate, 1999
- Myc—Max—Mad: a transcription factor network controlling cell cycle progression, differentiation and deathCurrent Opinion in Genetics & Development, 1994
- Oncogenic activity of the c-Myc protein requires dimerization with MaxCell, 1993